OLMA (STOCKS)
Olema Pharmaceuticals, Inc. Common Stock
$16.060000
-0.040000 (-0.25%)
Prev close: $16.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sean P. Bohen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,388.85M
- Employees
- 117
- P/E (TTM)
- -8.54
- P/B (TTM)
- 2.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $16.25M |
| Operating Expenses | $178.70M |
| Research and Development | $157.70M |
| Other Operating Expenses | $21.00M |
| Operating Income/Loss | -$178.70M |
| Income/Loss From Continuing Operations After Tax | -$162.45M |
| Income/Loss From Continuing Operations Before Tax | -$162.45M |
| Income Tax Expense/Benefit | $3.00K |
| Net Income/Loss | -$162.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$162.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$162.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.87 |
| Diluted Earnings Per Share | -$1.87 |
| Basic Average Shares | 87,006,027 |
| Diluted Average Shares | 87,006,027 |
| Assets | $533.43M |
| Current Assets | $515.45M |
| Cash | $505.40M |
| Other Current Assets | $10.05M |
| Noncurrent Assets | $17.98M |
| Fixed Assets | $274.00K |
| Other Non-current Assets | $17.70M |
| Liabilities | $54.87M |
| Current Liabilities | $51.80M |
| Accounts Payable | $9.25M |
| Wages | $1.15M |
| Other Current Liabilities | $41.40M |
| Noncurrent Liabilities | $3.07M |
| Equity | $478.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $478.56M |
| Liabilities And Equity | $533.43M |
| Net Cash Flow From Operating Activities | -$146.72M |
| Net Cash Flow From Operating Activities, Continuing | -$146.72M |
| Net Cash Flow From Investing Activities | -$155.76M |
| Net Cash Flow From Investing Activities, Continuing | -$155.76M |
| Net Cash Flow From Financing Activities | $211.30M |
| Net Cash Flow From Financing Activities, Continuing | $211.30M |
| Net Cash Flow | -$91.18M |
| Net Cash Flow, Continuing | -$91.18M |
| Comprehensive Income/Loss | -$161.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$161.97M |
| Other Comprehensive Income/Loss | $478.00K |